VVY Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vivoryon Therapeutics NV

Watchlist Manager

Watchlist

Price: 1.07 EUR -0.93% Market Closed

Market Cap: €31.7m

	Vivoryon Therapeutics NV AEX:VVY	DE
K	Kinross Gold Corp DUS:KIN2	CA
	British American Tobacco PLC LSE:BATS	UK
	COSCO SHIPPING Development Co Ltd OTC:CITAF	CN
O	Omega Healthcare Investors Inc F:WX4	US
H	Healthpeak Properties Inc F:HC5	US
	Allianz SE SIX:ALV	DE
F	First Industrial Realty Trust Inc BMV:FR	US
	Northeast Community Bancorp Inc NASDAQ:NECB	US
V	Vertex Pharmaceuticals Inc XBER:VX1	US
L	Lattice Semiconductor Corp XMUN:LTT	US

Profitability Summary

Vivoryon Therapeutics NV's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Sustainable 3Y Average Gross Margin

43%

Low Operating Margin

Strong 3Y Average Operating Margin

840%

Low Net Margin

Strong 3Y Average Net Margin

822%

Healthy Free Cash Flow Margin

Strong 3Y Average Free Cash Flow Margin

508%

Negative ROE

-145%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

2 009%

Declining ROIC

-3 165% > -3 588%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.